Drug intelligence / Profile preview

yoda1

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Yoda1 is a synthetic small molecule and the first known agonist of the mechanosensitive ion channel Piezo1. Piezo1 is involved in various physiological processes including regulation of blood pressure and red blood cell volume. Yoda1 activates purified Piezo1 channels in both human and mouse systems by eliciting calcium flux specifically in cells expressing Piezo1. It has been widely used as a research tool to study mechanotransduction pathways and the role of Piezo1 in vascular biology, neurobiology, lymphatic function, and disease models such as Alzheimer's disease. In preclinical studies, Yoda1 has demonstrated effects on endothelial signaling (e.g., Akt/ERK pathways), inhibition of Rac1-mediated actin rearrangement/macropinocytosis, improvement of brain lymphatic drainage functions related to neurodegenerative diseases like Alzheimer's disease, and modulation of cell survival/proliferation signaling[2][3][6].

Other names
2-[5-(2,6-dichlorobenzylsulfanyl)-[1,3,4]thiadiazol-2-yl]-pyrazineCAS 448947-81-7CAS448947-81-7CAS-448947-81-7
02

Targets

PIEZO1 (Piezo-type mechanosensitive ion channel component 1)

Beyond the preview

Go deeper on yoda1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yoda1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call